[Studies on the benzofuran series. XXVII. Antagonism of amiodarone with respect to certain cardiovascular and metabolic effects of catecholamines in dogs].
D000818:Animals; D000959:Antihypertensive Agents / Q000494:pharmacology* / Q000627:therapeutic use; D001572:Benzofurans / Q000494:pharmacology* / Q000627:therapeutic use; D001794:Blood Pressure / Q000187:drug effects; D003327:Coronary Disease / Q000188:drug therapy; D004285:Dogs; D004837:Epinephrine / Q000037:antagonists & inhibitors*; D005263:Femoral Artery; D006339:Heart Rate / Q000187:drug effects; D006973:Hypertension / Q000139:chemically induced; D009206:Myocardium / Q000378:metabolism*; D009638:Norepinephrine / Q000037:antagonists & inhibitors*; D010101:Oxygen Consumption / Q000187:drug effects*; D013610:Tachycardia / Q000139:chemically induced; D016276:Ventricular Function
D000959:Antihypertensive Agents; D001572:Benzofurans; D009638:Norepinephrine; D004837:Epinephrine
Recherches dans la série des benzofurannes. XXVII. Antagonisme de l'amiodarone vis-à-vis de certains effets cardiovasculaires et métaboliques des catécholamines chez le chien.